Those with Type 2 Diabetes* or Cardiovascular Risk Factors, such as high blood pressure, high cholesterol, or a history of heart disease with a body mass index (BMI) of 25 or higher are considered candidates for treatment
Along with diet and exercise, CONTRAVE, a weight-loss pill, is for adults with obesity or adults who are overweight and have weight-related medical problems
The test maps your response across GIPR, GLP1R, FTO, and MC4R variants, revealing which peptide compounds your body may tolerate best
Phase 2 data published in June showed that once-weekly CagriSema led to an average 15.6% bodyweight reduction at week 32 among type 2 diabetes patients living with overweight or obesity
It also includes weight charts that are color-coded by dose, day notes, side effect tracking, nutrition and exercise tracking through Apple Health sync, and estimated medication level charts